A topic in Clinical Evidence summarizes the evidence on sotalol in patients with myocardial infarction. One RCT (3 121 patients) included patients with left ventricular dysfunction. Sotalol increased mortality (AR for death 5% vs 3.1%, RR 1.65, 95% CI 1.15 to 2.36). The trial was terminated prematurely after less than 1 year.
The following decision support rules contain links to this evidence summary: